CHINO, Calif., April 18, 2025 (GLOBE NEWSWIRE) — The Board of Directors of Chino Commercial Bancorp (OTC: CCBC), the parent company of Chino Commercial Bank, N.A., announced the results of operations for the Bank and the consolidated holding company for the first quarter ended March 31, 2025.
Net earnings for the first quarter of 2025 were $1.35 million, reflecting an increase of $108.6 thousand, or 8.7%, compared to the same period last year. Basic and diluted earnings per share were $0.41 for the first quarter of 2025, up from $0.38 for the same quarter in 2024.
Dann H. Bowman, President and Chief Executive Officer, stated, “We are very pleased with the Bank’s performance in the first quarter of 2025. At the end of first quarter, the Bank set new records for total Assets, total Deposits, total Loans, and total Capital. Loan quality...
Availability of information relating to the Combined (Ordinary and Extraordinary) Shareholders’ Meeting of 22 May 2025
Written by Customer Service on . Posted in Public Companies.
Vallourec: Availability of information relating to the Combined (Ordinary and Extraordinary) Shareholders’ Meeting of 22 May 2025
Meudon (France), April 18, 2025
Vallourec’s Ordinary and Extraordinary Shareholders’ Meeting will be held on 22 May 2025 at 2:00 p.m. at Espace Verso, 52 rue de la Victoire 75009 Paris.
The prior notice of meeting published in the Bulletin des Annonces Légales Obligatoires of April 7, 2025, the notice of meeting including the agenda, draft resolutions and reports thereon, as well as the procedures for participating in the Meeting and voting are available on Vallourec’s website (www.vallourec.com). All useful information relating to this Meeting is regularly updated on this page of the website.
The documents referred to in Article R. 225-83 of the French...
AMG Signs Exclusive Agreement with Grupo Lagoa
Written by Customer Service on . Posted in Public Companies.
Amsterdam, 18 April 2025 — AMG Critical Materials N.V. (“AMG”, EURONEXT AMSTERDAM: “AMG”) announces that AMG Lithium BV has signed an exclusive agreement with Grupo Lagoa to become the first producer of spodumene concentrate in Portugal with an initial capacity of 8,000–9,000 tons per annum by the first half of 2027, pending government approvals. This exclusive agreement builds upon the positive results from our joint pre-engineering efforts since the first announcement of our partnership on August 17, 2023.
The capital expenditures of approximately 10 million Euros for this commercially sized pilot plant will be provided by AMG in the form of a loan to Grupo Lagoa. In exchange, AMG secures accelerated access to local production of spodumene in Europe to supply its lithium refinery in Germany. The supply from...
Long-Time Board Member Frances P. Philip Announces She Will Not Be Standing for Re-Election at 2025 Shareholder Meeting
Written by Customer Service on . Posted in Public Companies.
FORT WAYNE, Ind., April 18, 2025 (GLOBE NEWSWIRE) — Vera Bradley (NASDAQ: VRA) (the “Company”) today announced that long-time board member Frances P. Philip will not stand for re-election at the upcoming 2025 Shareholder Meeting.
Ms. Philip joined the Company’s Board in 2011 and has served as a member on both the Talent and Compensation Committee, as well as the Nominating, Governance and Sustainability Committee during her tenure. Ms. Philip has served as the Lead Independent Director since 2022, overseeing the Company’s business with insights stemming from the extensive product development, branding, marketing, and retail experience she possesses.
Robert Hall, Chairman of the Vera Bradley board of Directors, commented, “Frances has been a highly respected and influential member of the Company’s Board of Directors over the past...
Verizon to report earnings April 22, 2025
Written by Customer Service on . Posted in Public Companies.
NEW YORK, April 18, 2025 (GLOBE NEWSWIRE) — Verizon Communications Inc. (NYSE, Nasdaq: VZ) will report first-quarter 2025 earnings on Tuesday, April 22.
The company will present results on a webcast beginning at 8:30 a.m. Eastern Time. First-quarter 2025 materials will be available at 7:00 a.m. ET on Verizon’s Investor Relations website, https://www.verizon.com/about/investors. These materials will include:Detailed information on Verizon’s first quarter results, including a recording and transcript of management’s commentary;
Verizon’s earnings news release; and
Financial tables.Verizon Communications Inc. (NYSE, Nasdaq: VZ) powers and empowers how its millions of customers live, work and play, delivering on their demand for mobility, reliable network connectivity and security. Headquartered in New York City, serving...
Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)
Written by Customer Service on . Posted in Public Companies.
Approval based on Phase 3 trials demonstrating Dupixent significantly reduced itch and hives compared to placebo
In the U.S., there are more than 300,000 adults and adolescents aged 12 years and older living with CSU who remain symptomatic despite antihistamine treatment
CSU is the seventh disease with underlying type 2 inflammation in which Dupixent is approved
TARRYTOWN, N.Y. and PARIS, April 18, 2025 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent® (dupilumab) for the treatment of adults and adolescents aged 12 years and older with chronic spontaneous urticaria (CSU) who remain symptomatic despite histamine-1 (H1) antihistamine treatment.
“People with chronic spontaneous urticaria experience sudden, unpredictable...
Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria
Written by Customer Service on . Posted in Public Companies.
Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticariaApproval based on phase 3 studies demonstrating Dupixent significantly reduced itch and hives compared to placebo
In the US, there are more than 300,000 adults and adolescents aged 12 years and older living with CSU who remain symptomatic despite antihistamine treatment
CSU is the seventh disease with underlying type 2 inflammation in which Dupixent is approvedParis and Tarrytown, NY, April 18, 2025. The US Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for the treatment of adults and adolescents aged 12 years and older with chronic spontaneous urticaria (CSU) who remain symptomatic despite histamine-1 (H1) antihistamine treatment.
Kenneth MendezPresident and Chief Executive Officer at the Asthma and...
Christian Dior: 2024 Dividend
Written by Customer Service on . Posted in Dividend Reports And Estimates.
Paris, April 18th, 2025
2024 DIVIDEND
At the Annual Shareholders’ Meeting of Christian Dior held on Thursday, April 17th, 2025, approval was given for the payment of a dividend for financial year 2024 of 13 Euros per share.
Taking into account the 5.50 Euros paid on Wednesday, December 4th, 2024, the balance amounts to 7.50 Euros; it will be paid on Monday, April 28th, 2025. The last trading day with dividend rights is Wednesday, April 23rd, 2025.
This financial release is available on our website www.dior-finance.com.AttachmentChristian-Dior-Dividend-2024 EN
LVMH: 2024 Dividend
Written by Customer Service on . Posted in Public Companies.
Paris, Friday, April 18th, 2025
At the Annual Shareholders’ Meeting of LVMH Moët Hennessy Louis Vuitton held on Thursday, April 17th, 2025, approval was given for the payment of a dividend for financial year 2024 of 13.00 Euros per share.Taking into account the 5.50 Euros paid on Wednesday, December 4th, 2024, the balance of 7.50 Euros will be paid on Monday, April 28th, 2025. The last trading day with dividend rights is Wednesday, April 23rd, 2025.
LVMHLVMH Moët Hennessy Louis Vuitton is represented in Wines and Spirits by a portfolio of brands that includes Moët & Chandon, Dom Pérignon, Veuve Clicquot, Krug, Ruinart, Mercier, Château d’Yquem, Domaine du Clos des Lambrays, Château Cheval Blanc, Colgin Cellars, Hennessy, Glenmorangie, Ardbeg, Belvedere, Woodinville, Volcán de mi Tierra, Chandon, Cloudy Bay, Terrazas de los Andes,...
DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Written by Customer Service on . Posted in Public Companies.
Boulogne-Billancourt, April 18, 2025
Disclosure of Share Capital and Voting Rights(Pursuant to Article L.233-8 II of the French Commercial Code and Article 223-16 of the general Regulations of the Autorités des Marchés Financiers)
Registered name of the issuer: CEGEDIM SADate
Shares outstanding
Total potential voting rights
Exercisable voting rights*March 31, 2025
14,097,155
22,031,685
21,700,558* excluding rights attached to share held in treasuryAttachmentDisclosure-share-VR-31march2025